
News|Articles|November 5, 2025
Minimizing Fluid Loss by Monitoring Back Pressure during Clarification
Key Takeaways
- Peristaltic pumps are vital in biologics manufacturing but can fail under high back pressure, causing fluid loss and safety risks.
- A biopharma CDMO experienced a tubing rupture during lentivirus clarification, resulting in product loss and facility decontamination.
Peristaltic pumps are essential in biologics manufacturing but are prone to rupture or leaks when back pressure rises beyond design limits, leading to costly fluid loss and safety risks. This case study describes how a biopharma CDMO experienced a tubing rupture during lentivirus clarification, resulting in product loss, additional quality testing, and facility decontamination. The solution required minimal changes, offered straightforward validation, and provided robust process control.
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5


